Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
Mahindra Manulife Large & Mid Cap Fund Reg (G)
[Equity: Large & Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 30-Dec-19
Corpus(Cr.) 2784.0 Latest NAV 27.3204 As on 05-12-2025
Equity(%) 96.08 52 Week High 27.7862
Debt(%) 3.92 52 Week Low 22.8386
Others(%) 0.0 Exit Load 1% for redemption within 3 months
Minimum Investment - Availability Closed
Entry Load Nil Expense Ratio(%) 1.92
Scheme Benchmark NIFTY Large Midcap 250 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Manish Lodha
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The Scheme seeks long term capital growth through investments in equity and equity related securities of both large cap and mid cap stocks.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 16.51%
Top 10 Holdings 28.47%
Top 25 Holdings 57.48%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 23.65
Pharma & Biotech 13.43
Software & Services 6.94
Automobile 6.73
Industrial Products 5.71
Finance & Investments 5.33
Telecom 4.73
Retail 4.17
Healthcare 4.13
Cash 3.92
Chemicals 2.55
Construction 2.35
Consumer Durables 2.27
Ferrous Metals 2.27
Aerospace & Defence 1.78
FMCG 1.72
Energy 1.43
Miscellaneous 1.41
Electricals 1.19
Transportation 1.1
Petroleum Products 1.09
SERVICES 0.94
Oil & GAS 0.68
Fertilisers 0.48
 
 
 
 
 
Portfolio Metrics
PB Ratio 3.48
PE Ratio 27.93
 
Top 25 Holdings
Holdings Net Asset(%)
Indus Towers Limited 3.63
Triparty Repo 3.54
ICICI Bank Limited 3.26
Glenmark Pharmaceuticals Limited 3.05
DIVI LABORATORIES LTD 3.03
State Bank Of India 2.59
Axis Bank Limited 2.44
UltraTech Cement Limited 2.35
RBL Bank Limited 2.30
Fortis Health Care Ltd 2.28
JSW Steel Limited 2.27
Kaynes Technology India Limited 2.27
Federal Bank Limited 2.12
Laurus Labs Limited 2.12
IDFC First Bank Limited 2.09
Polycab India Limited 2.08
INDUSIND BANK 2.03
Angel One Limited 1.85
Senores Pharmaceuticals Limited 1.84
DLF Limited 1.81
Bajaj Finserv Limited 1.80
Dabur India Limited 1.72
Maruti Suzuki India Limited 1.70
Apollo Hospitals Enterprise Limited 1.66
Neuland Laboratories Limited 1.65

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.27% 3.45% 1.18% -0.60%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [NSE - Nifty Large Midcap 250 TRI]
1.73% 5.22% 3.78% 4.30%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
11.27% 15.33% 19.37% 0.00%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
15.54% 18.19% 20.44% 16.49%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Mahindra Manulife Large & Mid Cap Fund Reg (G) 13.92% 0.5000 14.2759% 42.2192 0.0789
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Mahindra Manulife Large & Mid Cap Fund Reg (G) 1.8402% 0.0004 0.0864 10.1617 0.3445
 
Back to Selection